Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

NCT01374360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6061

Last updated 2026-01-20

No results posted yet for this study

Summary

This study is a collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH).

Conditions

Sponsors & Collaborators

  • Alexion Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Phillipe Gustovic · Alexion Pharmaceuticals, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-29
Primary Completion
2025-04-14
Completion
2025-04-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01374360 on ClinicalTrials.gov